1. Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation 
Jaime M. Preussler, Christa L. Meyer, Lih-Wen Mau, Navneet S. Majhail, Ellen M. Denzen, Kristen C. Edsall, Stephanie H. Farnia, Wael Saber, Linda J. Burns, David J. Vanness 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 6, Pages (June 2017)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Patient selection [20].
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Adjusted costs at 3, 6, 9, 12, 18, and 24 months after AML diagnosis for patients who received chemotherapy alone or alloHCT who were continuously enrolled up to that time interval.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions